Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial

Screening for Type 2 diabetes. Lessons from the ADDITION-Europe study

(2011) M. van den Donk et al.   DIABETIC MEDICINE

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

(2011) Simon J Griffin et al.   LANCET

Screening for type 2 diabetes: an update of the evidence

(2010) R. K. Simmons et al.   DIABETES OBESITY & METABOLISM

Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study

(2010) L. A. Sargeant et al.   DIABETIC MEDICINE

Rationale and design of the ADDITION-Leicester study, a systematic screening programme and Randomised Controlled Trial of multi-factorial cardiovascular risk intervention in people with Type 2 Diabetes Mellitus detected by screening

(2010) DR Webb et al.   Trials

Comparison of 80 versus 10 mg of Atorvastatin on Occurrence of Cardiovascular Events After the First Event (from the Treating to New Targets [TNT] Trial)

(2009) John C. LaRosa et al.   AMERICAN JOURNAL OF CARDIOLOGY

The ADDITION-Cambridge trial protocol: a cluster – randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients

(2009) Justin B Echouffo-Tcheugui et al.   BMC PUBLIC HEALTH

Cardiovascular Outcomes in Randomized Trials

(2009) Steven E. Nissen   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Reduction in Recurrent Cardiovascular Events With Intensive Lipid-Lowering Statin Therapy Compared With Moderate Lipid-Lowering Statin Therapy After Acute Coronary Syndromes

(2009) Sabina A. Murphy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Total Cardiovascular Disease Burden: Comparing Intensive With Moderate Statin Therapy

(2009) Matti J. Tikkanen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

(2009) Kausik K Ray et al.   LANCET

Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study

(2008) Paul GH Janssen et al.   BRITISH JOURNAL OF GENERAL PRACTICE

Recurrence of Cardiovascular Events in Patients With Type 2 Diabetes: Epidemiology and risk factors

(2008) C. B. Giorda et al.   DIABETES CARE

Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study

(2008) A. Sandbaek et al.   DIABETOLOGIA

Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial

(2008) S. A. Murphy et al.   EUROPEAN HEART JOURNAL

Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

(2008) Peter Gæde et al.   NEW ENGLAND JOURNAL OF MEDICINE

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE